Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms

R. S. Burd, R. J. Battafarano, C. S. Cody, M. S. Farber, C. A. Ratz, D. L. Dunn, R. L. Simmons, Basil A Pruitt, R. W. Yurt, C. C. Baker

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To determine whether monoclonal antibodies (mAbs) directed against lipopolysaccharide (LPS, endotoxin) act by promoting LPS neutralization, LPS uptake by macrophages, or both processes, the authors assessed the effects of these agents on LPS-induced cytokine secretion and cellular uptake of LPS. Summary Background Data: MAbs directed against LPS have been shown to attenuate LPS-induced macrophage tumor necrosis factor-α (TNF-α) secretion, a process that may contribute to protective capacity. The mechanisms by which this process occurs have not been established. Methods: MAbs directed against LPS were evaluated in vitro for their capacity to (1) inhibit TNF-α secretion, and (2) alter fluorescein isothiocyanate-labeled LPS uptake (employing flow cytometry analysis and fluorescence microscopy) by the macrophage-like cell line RAW 264.7. Results: MAb 8G9, an IgG3 directed against the O-antigen polysaccharide region of Escherichia coli 0111:B4 LPS, significantly reduced LPS-induced TNF-α secretion and promoted a more than 40-fold increase in LPS uptake by macrophages. The authors established that this was mediated by a Fc receptor-mediated process because 8G9 F(ab')2 fragments that lack the Fc portion of the IgG molecule were capable of inhibiting TNF-α secretion, but did not promote increased LPS uptake to the same degree. Cross-reactive, anti-deep core/lipid A mAb 1B6, an IgG(2a), also promoted uptake of E. coli 0111:B4 LPS and O-antigen polysaccharide-deficient E. coli J5 LPS, but only inhibited TNF-α secretion induced by E. coli J5 LPS to which it binds most efficiently MAb 3D10, an IgM also directed against the O-antigen polysaccharide region of E. coli 0111:B4 LPS, inhibited TNF-α secretion but did not increase cellular uptake of LPS, presumably acting solely due to LPS neutralization. Polymyxin B, an antibiotic that binds stoichiometrically to the lipid A portion of LPS, inhibited TNF-α secretion and prevented cellular LPS uptake. Conclusions: These results suggest that IgG and IgM anti-LPS mAbs exert protective capacity by extracellular neutralization of LPS, while IgG Fc receptor-mediated cellular uptake also may serve to bypass macrophage activation and TNF-α secretion by promoting internalization and intracellular neutralization.

Original languageEnglish (US)
Pages (from-to)250-261
Number of pages12
JournalAnnals of Surgery
Volume218
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Tumor Necrosis Factor-alpha
Monoclonal Antibodies
O Antigens
Escherichia coli
Macrophages
Polysaccharides
Lipid A
Fc Receptors
Immunoglobulin G
Immunoglobulin Fc Fragments
IgG Receptors
Polymyxin B
Macrophage Activation
antilipopolysaccharide antibodies
Secretory Pathway
Fluorescein
Fluorescence Microscopy
Endotoxins
Immunoglobulin M
Lipopolysaccharides

ASJC Scopus subject areas

  • Surgery

Cite this

Burd, R. S., Battafarano, R. J., Cody, C. S., Farber, M. S., Ratz, C. A., Dunn, D. L., ... Baker, C. C. (1993). Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms. Annals of Surgery, 218(3), 250-261.

Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms. / Burd, R. S.; Battafarano, R. J.; Cody, C. S.; Farber, M. S.; Ratz, C. A.; Dunn, D. L.; Simmons, R. L.; Pruitt, Basil A; Yurt, R. W.; Baker, C. C.

In: Annals of Surgery, Vol. 218, No. 3, 1993, p. 250-261.

Research output: Contribution to journalArticle

Burd, RS, Battafarano, RJ, Cody, CS, Farber, MS, Ratz, CA, Dunn, DL, Simmons, RL, Pruitt, BA, Yurt, RW & Baker, CC 1993, 'Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms', Annals of Surgery, vol. 218, no. 3, pp. 250-261.
Burd RS, Battafarano RJ, Cody CS, Farber MS, Ratz CA, Dunn DL et al. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms. Annals of Surgery. 1993;218(3):250-261.
Burd, R. S. ; Battafarano, R. J. ; Cody, C. S. ; Farber, M. S. ; Ratz, C. A. ; Dunn, D. L. ; Simmons, R. L. ; Pruitt, Basil A ; Yurt, R. W. ; Baker, C. C. / Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms. In: Annals of Surgery. 1993 ; Vol. 218, No. 3. pp. 250-261.
@article{e6320aacf77448aa99a31f86e59b6d50,
title = "Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms",
abstract = "Objective: To determine whether monoclonal antibodies (mAbs) directed against lipopolysaccharide (LPS, endotoxin) act by promoting LPS neutralization, LPS uptake by macrophages, or both processes, the authors assessed the effects of these agents on LPS-induced cytokine secretion and cellular uptake of LPS. Summary Background Data: MAbs directed against LPS have been shown to attenuate LPS-induced macrophage tumor necrosis factor-α (TNF-α) secretion, a process that may contribute to protective capacity. The mechanisms by which this process occurs have not been established. Methods: MAbs directed against LPS were evaluated in vitro for their capacity to (1) inhibit TNF-α secretion, and (2) alter fluorescein isothiocyanate-labeled LPS uptake (employing flow cytometry analysis and fluorescence microscopy) by the macrophage-like cell line RAW 264.7. Results: MAb 8G9, an IgG3 directed against the O-antigen polysaccharide region of Escherichia coli 0111:B4 LPS, significantly reduced LPS-induced TNF-α secretion and promoted a more than 40-fold increase in LPS uptake by macrophages. The authors established that this was mediated by a Fc receptor-mediated process because 8G9 F(ab')2 fragments that lack the Fc portion of the IgG molecule were capable of inhibiting TNF-α secretion, but did not promote increased LPS uptake to the same degree. Cross-reactive, anti-deep core/lipid A mAb 1B6, an IgG(2a), also promoted uptake of E. coli 0111:B4 LPS and O-antigen polysaccharide-deficient E. coli J5 LPS, but only inhibited TNF-α secretion induced by E. coli J5 LPS to which it binds most efficiently MAb 3D10, an IgM also directed against the O-antigen polysaccharide region of E. coli 0111:B4 LPS, inhibited TNF-α secretion but did not increase cellular uptake of LPS, presumably acting solely due to LPS neutralization. Polymyxin B, an antibiotic that binds stoichiometrically to the lipid A portion of LPS, inhibited TNF-α secretion and prevented cellular LPS uptake. Conclusions: These results suggest that IgG and IgM anti-LPS mAbs exert protective capacity by extracellular neutralization of LPS, while IgG Fc receptor-mediated cellular uptake also may serve to bypass macrophage activation and TNF-α secretion by promoting internalization and intracellular neutralization.",
author = "Burd, {R. S.} and Battafarano, {R. J.} and Cody, {C. S.} and Farber, {M. S.} and Ratz, {C. A.} and Dunn, {D. L.} and Simmons, {R. L.} and Pruitt, {Basil A} and Yurt, {R. W.} and Baker, {C. C.}",
year = "1993",
language = "English (US)",
volume = "218",
pages = "250--261",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-α by two distinct mechanisms

AU - Burd, R. S.

AU - Battafarano, R. J.

AU - Cody, C. S.

AU - Farber, M. S.

AU - Ratz, C. A.

AU - Dunn, D. L.

AU - Simmons, R. L.

AU - Pruitt, Basil A

AU - Yurt, R. W.

AU - Baker, C. C.

PY - 1993

Y1 - 1993

N2 - Objective: To determine whether monoclonal antibodies (mAbs) directed against lipopolysaccharide (LPS, endotoxin) act by promoting LPS neutralization, LPS uptake by macrophages, or both processes, the authors assessed the effects of these agents on LPS-induced cytokine secretion and cellular uptake of LPS. Summary Background Data: MAbs directed against LPS have been shown to attenuate LPS-induced macrophage tumor necrosis factor-α (TNF-α) secretion, a process that may contribute to protective capacity. The mechanisms by which this process occurs have not been established. Methods: MAbs directed against LPS were evaluated in vitro for their capacity to (1) inhibit TNF-α secretion, and (2) alter fluorescein isothiocyanate-labeled LPS uptake (employing flow cytometry analysis and fluorescence microscopy) by the macrophage-like cell line RAW 264.7. Results: MAb 8G9, an IgG3 directed against the O-antigen polysaccharide region of Escherichia coli 0111:B4 LPS, significantly reduced LPS-induced TNF-α secretion and promoted a more than 40-fold increase in LPS uptake by macrophages. The authors established that this was mediated by a Fc receptor-mediated process because 8G9 F(ab')2 fragments that lack the Fc portion of the IgG molecule were capable of inhibiting TNF-α secretion, but did not promote increased LPS uptake to the same degree. Cross-reactive, anti-deep core/lipid A mAb 1B6, an IgG(2a), also promoted uptake of E. coli 0111:B4 LPS and O-antigen polysaccharide-deficient E. coli J5 LPS, but only inhibited TNF-α secretion induced by E. coli J5 LPS to which it binds most efficiently MAb 3D10, an IgM also directed against the O-antigen polysaccharide region of E. coli 0111:B4 LPS, inhibited TNF-α secretion but did not increase cellular uptake of LPS, presumably acting solely due to LPS neutralization. Polymyxin B, an antibiotic that binds stoichiometrically to the lipid A portion of LPS, inhibited TNF-α secretion and prevented cellular LPS uptake. Conclusions: These results suggest that IgG and IgM anti-LPS mAbs exert protective capacity by extracellular neutralization of LPS, while IgG Fc receptor-mediated cellular uptake also may serve to bypass macrophage activation and TNF-α secretion by promoting internalization and intracellular neutralization.

AB - Objective: To determine whether monoclonal antibodies (mAbs) directed against lipopolysaccharide (LPS, endotoxin) act by promoting LPS neutralization, LPS uptake by macrophages, or both processes, the authors assessed the effects of these agents on LPS-induced cytokine secretion and cellular uptake of LPS. Summary Background Data: MAbs directed against LPS have been shown to attenuate LPS-induced macrophage tumor necrosis factor-α (TNF-α) secretion, a process that may contribute to protective capacity. The mechanisms by which this process occurs have not been established. Methods: MAbs directed against LPS were evaluated in vitro for their capacity to (1) inhibit TNF-α secretion, and (2) alter fluorescein isothiocyanate-labeled LPS uptake (employing flow cytometry analysis and fluorescence microscopy) by the macrophage-like cell line RAW 264.7. Results: MAb 8G9, an IgG3 directed against the O-antigen polysaccharide region of Escherichia coli 0111:B4 LPS, significantly reduced LPS-induced TNF-α secretion and promoted a more than 40-fold increase in LPS uptake by macrophages. The authors established that this was mediated by a Fc receptor-mediated process because 8G9 F(ab')2 fragments that lack the Fc portion of the IgG molecule were capable of inhibiting TNF-α secretion, but did not promote increased LPS uptake to the same degree. Cross-reactive, anti-deep core/lipid A mAb 1B6, an IgG(2a), also promoted uptake of E. coli 0111:B4 LPS and O-antigen polysaccharide-deficient E. coli J5 LPS, but only inhibited TNF-α secretion induced by E. coli J5 LPS to which it binds most efficiently MAb 3D10, an IgM also directed against the O-antigen polysaccharide region of E. coli 0111:B4 LPS, inhibited TNF-α secretion but did not increase cellular uptake of LPS, presumably acting solely due to LPS neutralization. Polymyxin B, an antibiotic that binds stoichiometrically to the lipid A portion of LPS, inhibited TNF-α secretion and prevented cellular LPS uptake. Conclusions: These results suggest that IgG and IgM anti-LPS mAbs exert protective capacity by extracellular neutralization of LPS, while IgG Fc receptor-mediated cellular uptake also may serve to bypass macrophage activation and TNF-α secretion by promoting internalization and intracellular neutralization.

UR - http://www.scopus.com/inward/record.url?scp=0027166160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027166160&partnerID=8YFLogxK

M3 - Article

C2 - 8373268

AN - SCOPUS:0027166160

VL - 218

SP - 250

EP - 261

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -